TASE:NICESoftware
NICE (TASE:NICE) Wins Bluecrest Deal After AI Narrative Puts Valuation Back In Focus
News around NICE (TASE:NICE) today centers on Bluecrest Health Intelligence’s move to an AI-enabled contact center model using the CXone platform, highlighting how the company’s technology is being applied in real-world healthcare operations.
Despite the Bluecrest win and other recent CXone client additions, momentum in NICE’s share price has been mixed. The company has a 90-day share price return of 12.09%, a year-to-date share price decline of 14.53%, and a 1-year total shareholder return...